Biessels Geert Jan, Kerssen Anneloes, de Haan Edward H F, Kappelle L Jaap
Department of Neurology, Rudolf Magnus Institute of Neurosciences, University Medical Center Utrecht, The Netherlands.
Prim Care Diabetes. 2007 Dec;1(4):187-93. doi: 10.1016/j.pcd.2007.10.002. Epub 2007 Nov 26.
It is increasingly recognized that diabetes mellitus can lead to long-term complications in the brain. Clinically, these complications are manifested in alterations in cognitive functioning. This paper offers an overview on the impact of diabetes on cognition and provides leads for the evaluation and management of cognitive disturbances in patients with diabetes in a primary care setting. The main message is that while some patient groups appear to be at increased risk of cognitive impairments, in the majority of patients diabetes is not associated with the development cognitive decrements that would be regarded as clinically relevant. Frank impairments of cognition mainly occur in patients above the age of 65, often in association with vascular co-morbidity. Other groups at risk for cognitive decrements are children with an early age at diabetes onset and patients with clinically manifest retinopathy or other microvascular complications. No specific treatment options are available, but for now treatment of vascular risk factors and attention for glycaemic control appears to be a logical approach. Given the recent progress in this field, new treatments to prevent cognitive impairment in patients with diabetes may hopefully become available in the near future.
人们越来越认识到,糖尿病会导致大脑出现长期并发症。临床上,这些并发症表现为认知功能的改变。本文概述了糖尿病对认知的影响,并为基层医疗环境中糖尿病患者认知障碍的评估和管理提供了线索。主要信息是,虽然一些患者群体似乎认知障碍风险增加,但在大多数患者中,糖尿病与临床上相关的认知能力下降并无关联。明显的认知障碍主要发生在65岁以上的患者中,通常与血管合并症有关。其他有认知能力下降风险的群体包括糖尿病发病年龄较小的儿童以及有临床明显视网膜病变或其他微血管并发症的患者。目前尚无具体的治疗选择,但目前治疗血管危险因素并关注血糖控制似乎是一种合理的方法。鉴于该领域最近的进展,有望在不久的将来出现预防糖尿病患者认知障碍的新疗法。